Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0264-2027

Generic Name: restor3d MTP Implant Generic Name: MTP Implant Model/Catalog Number: 1103-161620 Software Version: None Product Description: The restor3d Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, available in varied articulating surface coverages. The restor3d MTP implant is designed to replace the damaged articulating surface of the first metatarsal distal head. The device is intended for the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head. This implant can also be used in the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The implant is a single use product intended to be press fit, with optional use of bone cement. The restor3d MTP Implant is comprised of a single laser powder bed fusion (LPBF) printed cobalt-chromium alloy (Co28Cr6Mo) part. The external surface of the implant that is intended to be in contact with the phalanx is mirror polished. Component: Not a component

Publicado el 28 de octubre de 2026 · Inicio del retiro: 4 de septiembre de 2026

Resumen

FDA registra el retiro Z-0264-2027 de dispositivos médicos de Clase II, publicado el 28 de octubre de 2026 e iniciado el 4 de septiembre de 2026. Empresa responsable: restor3d Inc.; Estado: En curso; Cantidad reportada: 16; Lote: Lot Code: Model: 1103-161620 UDI: 00840097505244 Lot: A02979. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
restor3d Inc.
Distribuidor
U.S. Nationwide distribution in the states of FL, IL, NC, PA, SC, and TX.
Lote
Lot Code: Model: 1103-161620 UDI: 00840097505244 Lot: A02979
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Generic Name: restor3d MTP Implant Generic Name: MTP Implant Model/Catalog Number: 1103-161620 Software Version: None Product Description: The restor3d Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, available in varied articulating surface coverages. The restor3d MTP implant is designed to replace the damaged articulating surface of the first metatarsal distal head. The device is intended for the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head. This implant can also be used in the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The implant is a single use product intended to be press fit, with optional use of bone cement. The restor3d MTP Implant is comprised of a single laser powder bed fusion (LPBF) printed cobalt-chromium alloy (Co28Cr6Mo) part. The external surface of the implant that is intended to be in contact with the phalanx is mirror polished. Component: Not a component fue retirado del mercado?

Sí. FDA publicó el retiro Z-0264-2027 el 28 de octubre de 2026. Peligro reportado: Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter